FMP

FMP

Enter

NEPH - Nephros, Inc.

Financial Summary of Nephros, Inc.(NEPH), Nephros, Inc. develops and sells high performance water solutions to the medical and commercial mark

photo-url-https://financialmodelingprep.com/image-stock/NEPH.png

Nephros, Inc.

NEPH

NASDAQ

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

2.1 USD

0.11 (5.24%)

About

ceo

Mr. Daron G. Evans M.B.A., M.S.

sector

Healthcare

industry

Medical - Instruments & Supplies

website

https://www.nephros.com

exchange

NASDAQ

Description

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; ...

CIK

0001196298

ISIN

US6406714005

CUSIP

640671400

Address

380 Lackawanna Place

Phone

201 343 5202

Country

US

Employee

31

IPO Date

Sep 21, 2004

Summary

CIK

0001196298

Exchange

NASDAQ

Industry

Medical - Instrument...

Sector

Healthcare

CUSIP

640671400

ISIN

US6406714005

Country

US

Price

2.1

Beta

1.26

Volume Avg.

19.35k

Market Cap

22.14M

Shares

-

52-Week

1.13-4.04

DCF

1.69

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-14

P/B

-

Website

https://www.nephros.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest NEPH News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep